- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| T&E Specialist | Moscow (City) | Russian Fed. | Finance | CTS | Audit & Finance | Nov 21, 2024 |
| Key Account Manager | Irkutsk | Russian Fed. | International | Innovative Medicines | Sales | Nov 13, 2024 |
| Senior Product Manager | Moscow (City) | Russian Fed. | International | Innovative Medicines | Marketing | Nov 13, 2024 |
| Региональный коммерческий менеджер | Vladimir | Russian Fed. | International | Innovative Medicines | Sales | Nov 05, 2024 |
| R2R Accountant | Moscow (City) | Russian Fed. | Finance | CTS | Audit & Finance | Oct 22, 2024 |
| Специалист по системе качества | St. Petersburg (City) | Russian Fed. | Operations | Innovative Medicines | Quality | Oct 22, 2024 |
| Hematology Area Manager | Novosibirsk | Russian Fed. | International | Innovative Medicines | Sales | Oct 22, 2024 |
| Hematology Area Manager | Moscow (City) | Russian Fed. | International | Innovative Medicines | Sales | Oct 22, 2024 |
| Government Affairs Manager | Moscow (City) | Russian Fed. | Corporate Affairs | Innovative Medicines | Communications & Public Affairs | Oct 22, 2024 |
| H2R Services Expert | Moscow (City) | Russian Fed. | People & Organization | CTS | Human Resources | Oct 16, 2024 |
| H2R Services Expert | Moscow (City) | Russian Fed. | People & Organization | CTS | Human Resources | Oct 15, 2024 |
| Key Account Manager | Novokuznetsk | Russian Fed. | International | Innovative Medicines | Sales | Sep 25, 2024 |
| Medical Science Liaison Hemato (Siberia) | Novosibirsk | Russian Fed. | International | Innovative Medicines | Research & Development | Sep 20, 2024 |
| Treasury Manager | Moscow (City) | Russian Fed. | Finance | CTS | Audit & Finance | Jun 20, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى